Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/28/2018 |
| Start Date: | August 2011 |
| End Date: | July 2014 |
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application
(also often referred to as corneal collagen crosslinking) as a method to enhance treatment of
infectious keratitis.
(also often referred to as corneal collagen crosslinking) as a method to enhance treatment of
infectious keratitis.
Inclusion Criteria:
1. Subjects must be 18 years of age or older.
2. Ability to provide written informed consent.
3. Likely to complete all study visits.
4. Subjects must have one eye that with a diagnosis of infectious keratitis.
Exclusion Criteria:
1. A corneal perforation.
2. Descemetocele.
3. Pregnancy or breastfeeding.
4. Active Herpes corneal disease.
5. Patient is unwilling or unable to comply with a medication regimen and follow up
appointments.
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials